Milan, Italy

Renato Pellegata


Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1977-1984

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Inventor Renato Pellegata: Innovations in Fluoro-Prostaglandins

Introduction

Renato Pellegata, an inventive mind based in Milan, Italy, has made significant contributions to the field of pharmaceuticals, particularly in the development of fluoro-prostaglandins. With a total of 13 patents to his name, his work has been instrumental in advancing therapeutic uses in medicine.

Latest Patents

Among his latest patents, the development of fluoro-prostaglandin compounds stands out. These compounds, such as 18,19,20-trinor-17-cyclohexyl-16(S,R)-fluoro-PGF2α, have shown promise in therapeutic applications similar to those of natural prostaglandins. However, they possess key advantages, including resistance to the enzyme 15-prostaglandin dehydrogenase, leading to a more selective therapeutic action. Moreover, certain compounds have demonstrated favorable luteolytic and antiulcer activities, marking a significant step forward in the pharmaceutical landscape.

Career Highlights

Renato has had a profound impact during his career, working with notable companies such as Carlo Erba S.p.A. and Farmitalia Carlo Erba. His expertise and innovative spirit have allowed him to excel in environments that challenge the boundaries of pharmaceutical development.

Collaborations

Throughout his career, Renato has collaborated with esteemed colleagues, including Carmelo Gandolfi and Maria M Usardi. These partnerships have likely facilitated the exchange of ideas and enhanced the innovation process, contributing to the successful development of his patented compounds.

Conclusion

Renato Pellegata's work in the realm of fluoro-prostaglandins exemplifies his dedication and ingenuity as an inventor. With his impressive portfolio of patents and collaborative efforts, he continues to influence pharmaceutical research and development, paving the way for advancements that can enhance therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…